Trading of Champignon Brands (SHRM) on the Canadian Securities Exchange has been temporarily halted due to the failure to file necessary disclosures with respect to recent acquisitions.
Trading of Champignon Brands (SHRM) on the Canadian Securities Exchange has been temporarily halted due to the failure to file necessary disclosures with respect to recent acquisitions.
Canadians are rapidly warming up to the idea of using psilocybin to reduce distress among the terminally ill.
Compass appoints a new Chief Development Officer as part of several new appointments to its management team.
Mydecine's new Scientific Advisor will work directly with the CSO in new drug development initiatives.
MindMed files patent applications for technologies to screen and optimize dosing of MDMA and LSD.
Numinus' new Clinical Advisory Council will provide support for its psychedelic drug R&D at all levels.
ATAI is adding a digital therapeutics division to its R&D platform.
Given that psychedelics micro-dosing has several commercial advantages, here are two companies that investors should look at.
Wuhan General lines up capsule manufacturer, specializing in coffee pods.
Former Canada Health Minister joins Red Light Holland as Senior Advisor.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now